CN Stock MarketDetailed Quotes

Xizang Weixinkang Pharmaceutical (603676)

Watchlist
  • 9.82
  • -0.24-2.39%
Market Closed May 18 15:00 CST
4.27BMarket Cap19.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xizang Weixinkang Pharmaceutical (603676) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Service income811.87M71.48%
微量元素类141.07M12.42%
Other111.01M9.77%
电解质类71.8M6.32%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry1.14B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Central China272.18M23.96%
East China254.96M22.45%
North China231.37M20.37%
South China124.8M10.99%
Southwest120.95M10.65%
Northeast China74.59M6.57%
Northwest56.9M5.01%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +2.81%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.82%
4
SINOPEC CORP
00386
-1.54%
5
SHANGHAI PECHEM
00338
-2.36%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +36.67%
Sample Name
Sample Code
 +29.14%
Sample Name
Sample Code
 +25.72%
4
Digital China Group
000034
+19.11%
5
Business-intelligence Of Oriental Nations Corporation
300166
+17.75%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -